Screener
G&A at other companies
Other financials
Where this comes from
Reported directly by Beta Bionics in its filing.
Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.
The source filing: Beta Bionics’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:20 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-323777
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Operating expenses: | ||||
| Research and development | 10,240 | 8,873 | 20,596 | 16,463 |
| Sales and marketing | 24,640 | 15,623 | 45,375 | 29,025 |
| General and administrative | 9,600 | 7,879 | 19,217 | 14,500 |
| Total operating expenses | 44,480 | 32,375 | 85,188 | 59,988 |
| Loss from operations | (25,578) | (19,872) | (49,849) | (38,514) |
| Other income (expense): | ||||
| Interest income | 2,177 | 3,005 | 4,553 | 5,441 |
Item 1. Financial Statements.
FAQ
- What is Beta Bionics's G&A?
- Beta Bionics (BBNX) reported G&A of $9.6M in Q2 2026.
- How has Beta Bionics's G&A changed year-over-year?
- Beta Bionics's G&A increased by 21.8% year-over-year, from $7.88M to $9.6M.
- What is the long-term trend for Beta Bionics's G&A?
- Over 2 years (2023 to 2025), Beta Bionics's G&A has grown at a 59.3% compound annual growth rate (CAGR), from $12.23M to $31.03M.
- What does G&A mean?
- Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.
Ask your AI about Beta Bionics's g&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude